Health and Fitness Health and Fitness
Thu, February 23, 2012
[ Thu, Feb 23rd 2012 ] - Market Wire
Forest and Almirall Announce Positive FDA Advisor .. for Approval of Aclidinium Bromide for the Treatm
[ Thu, Feb 23rd 2012 ] - Market Wire
Brookdale to Present at Citi's 2012 Global Health Care Conference on February 28
[ Thu, Feb 23rd 2012 ] - Market Wire
Clovis Oncology to Announce Fourth Quarter and Ye .. Results, Host Webcast Conference Call on March 8
[ Thu, Feb 23rd 2012 ] - Market Wire
Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Amgen to Present at the Citi 2012 Global Healthcare Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Data Published in the Journal of the American Soc .. y Home Hemodialysis Patients with the NxStage Sys
[ Thu, Feb 23rd 2012 ] - Market Wire
Anthera Pharmaceuticals to Present at the Citi Global Health Care Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
30 p.m. ET to Discuss Financial Results for the Fourth Quarter and Year Ended 2011
[ Thu, Feb 23rd 2012 ] - Market Wire
BioSpecifics Announces Partnership Between Auxili .. r XIAFLEX in Canada, Australia, Brazil and Mexico
[ Thu, Feb 23rd 2012 ] - Market Wire
Sirona Biochem Announces Preclinical Results of Diabetes Compound
[ Thu, Feb 23rd 2012 ] - Market Wire
IRIDEX Announces Fourth Quarter and Full Year 2011 Conference Call and Release Date
[ Thu, Feb 23rd 2012 ] - Market Wire
Telik Announces Fourth Quarter and 2011 Year End Financial Results and 2012 Financial Guidance
[ Thu, Feb 23rd 2012 ] - Market Wire
Vermillion Reports Preliminary Fourth Quarter and Full Year 2011 Results
[ Thu, Feb 23rd 2012 ] - Market Wire
Idenix Pharmaceuticals Reports Fourth Quarter and .. 11 Financial Results and Provides Pipeline Update
[ Thu, Feb 23rd 2012 ] - Market Wire
Savient Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
YM BioSciences Announces Proposed Public Offering of Common Shares
[ Thu, Feb 23rd 2012 ] - Market Wire
Avid Bioservices to Present at IBC's Antibody Development and Production Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Gentiva Health Services to Present at the RBC Capital Markets 2012 Global Healthcare Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
CML HealthCare Inc. Announces Release Date for Fourth Quarter 2011 Financial Results
[ Thu, Feb 23rd 2012 ] - Market Wire
Aetnaas 2012 African American History Calendar Highlights Entrepreneurship in the Community
[ Thu, Feb 23rd 2012 ] - Market Wire
XenoPort to Present at the RBC Capital Markets' Healthcare Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
National Health Scan Inc. (NHSN) Merger Introduction
[ Thu, Feb 23rd 2012 ] - Market Wire
Acura Pharmaceuticals to Report Fourth Quarter and Fiscal Year 2011 Financial Results
[ Thu, Feb 23rd 2012 ] - Market Wire
DURECT to Participate in Upcoming Healthcare Conferences
[ Thu, Feb 23rd 2012 ] - Market Wire
Care360 EHR From Quest Diagnostics Honored by Bla .. k Book's 2012 Rankings and Capterra's Top 20 List
[ Thu, Feb 23rd 2012 ] - Market Wire
Cigna Corporation Announces Appearance at the Citi 2012 Global Health Care Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Abbott Collaborates with Leading U.S. Forensics Center on Human Identification Testing
[ Thu, Feb 23rd 2012 ] - Market Wire
Medtronic CFO Gary Ellis to Speak at Citi Healthcare Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Theratechnologies to Present at RBC Capital Markets Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
OPKO Health to Present at the Citi 2012 Global Health Care Conference

OPKO Health to Present at the Citi 2012 Global Health Care Conference


Published on 2012-02-23 07:00:37 - Market Wire
  Print publication without navigation


MIAMI--([ ])--OPKO Health, Inc. (NYSE: OPK) today announced that senior management will present at the Citi 2012 Global Health Care Conference on Monday, February 27, 2012 at 4:00 PM EST. The conference will be held at The Waldorf Astoria Hotel in New York City.

About OPKO Health, Inc.

OPKO is a multi-national biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large and rapidly growing medical markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies.

Contributing Sources